Skip to content

Careers
Contacts

Profile
Technology
Portfolio
Investors
Press Releases

Transgene Presents its Individualized Immunotherapy, TG4050, at the Annual Neoantigen Based Therapies Summit

20201105 TG – Neoantigen summit presentation

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

© 2025 Transgene - All rights reserved
Credits